The Risk of Venous Thromboembolism Events Resulting in Hospitalization following Exposure to Antipsychotic Medication in Pre-Disposed Adult Patients

Introduction:  The primary objective of this study was to compare the incidence of antipsychotic use in those with venous thromboembolism (VTE) resulting in hospital admission. This study expands upon current knowledge regarding VTE risk and antipsychotic use and investigates potential risk factors...

Full description

Saved in:
Bibliographic Details
Main Authors: Rachel Kahle (Author), Laura Sjoquist (Author), Lindsey Peters (Author)
Format: Book
Published: University of Minnesota Libraries Publishing, 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_05d4a7c8bacb41a8b852a5fb6af7a531
042 |a dc 
100 1 0 |a Rachel Kahle  |e author 
700 1 0 |a Laura Sjoquist  |e author 
700 1 0 |a Lindsey Peters  |e author 
245 0 0 |a The Risk of Venous Thromboembolism Events Resulting in Hospitalization following Exposure to Antipsychotic Medication in Pre-Disposed Adult Patients 
260 |b University of Minnesota Libraries Publishing,   |c 2024-06-01T00:00:00Z. 
500 |a 10.24926/iip.v15i2.6116 
500 |a 2155-0417 
520 |a Introduction:  The primary objective of this study was to compare the incidence of antipsychotic use in those with venous thromboembolism (VTE) resulting in hospital admission. This study expands upon current knowledge regarding VTE risk and antipsychotic use and investigates potential risk factors and lab values that may precede antipsychotic-induced coagulopathy. Methods:  This retrospective, case-control, chart review investigated patients admitted to an acute care hospital with either a VTE or non-VTE diagnosis. Primary outcome analysis compared the presence of an antipsychotic medication in patients who had a VTE versus those who did not. Secondary analysis included: 1) the duration, class, dose, frequency, and route of antipsychotic and 2) coagulation parameters, patient characteristics, and VTE risk factors. Results: Analysis included 400 participants with 200 participants in each group (VTE and non-VTE).  Of the 51 patients who received an antipsychotic, 29 (56.9%) developed or presented with a VTE. However, there was no significant difference in VTE development between groups when controlled for antipsychotic use (OR 1.37, 95% CI 0.76-2.50, P-value=0.30). Conclusion: While primary study findings were not statistically significant, results support a weak association of exposure to antipsychotic(s) in VTE groups compared to control (non-VTE).  Obesity significantly increased the odds of VTE whereas a history of type 2 diabetes significantly decreased the odds of VTE. 
546 |a EN 
690 |a venous thromboembolism 
690 |a deep vein thrombosis 
690 |a antipsychotic agents 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n INNOVATIONS in Pharmacy, Vol 15, Iss 2 (2024) 
787 0 |n https://pubs.lib.umn.edu/index.php/innovations/article/view/6116 
787 0 |n https://doaj.org/toc/2155-0417 
856 4 1 |u https://doaj.org/article/05d4a7c8bacb41a8b852a5fb6af7a531  |z Connect to this object online.